No Data
No Data
Polyrizon Announces The Initiation Of Preclinical Studies For Intranasal Benzodiazepines, A Treatment For Acute Repetitive Seizures And Status Epilepticus, Using Its Proprietary Drug Delivery Platform
Express News | Polyrizon Expands Drug Delivery Innovation With Preclinical Studies for Epilepsy Rescue Treatment
12 Health Care Stocks Moving In Monday's After-Market Session
Clearmind Medicine To Develop Novel Intranasal Formulation With Polyrizon
Clearmind Medicine Announced That It Has Signed A Non-binding Letter Of Intent With Polyrizon To Develop A Novel Intranasal Formulation For Its Psychedelic-based Treatment Applications
Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination